Stéphane Depil
Impact in
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Histone Deacetylase Inhibitors Research 10
- Protein Degradation and Inhibitors 9
- vaccines and immunoinformatics approaches 6
- Oncology 31
- CAR-T cell therapy research 13
- Viral-associated cancers and disorders 6
- Co-authors
- Laurent Poirot (5 shared papers)Philippe Duchâteau (4 shared papers)G J Mufti (1 shared paper)Stephan A. Grupp (1 shared paper)Vincent Alcazer (12 shared papers)Christophe Caux (7 shared papers)Jenny Valladeau‐Guilemond (5 shared papers)Paola Bonaventura (7 shared papers)
- Journals
- Cancer Research (8 papers)European Journal of Cancer (3 papers)Annals of Oncology (3 papers)Molecular Cancer Therapeutics (3 papers)PLoS ONE (3 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Stéphane Depil
67 papers receiving 3.9k citations
Stéphane Depil's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 2.4k
- Immunology 1.6k
- Molecular Biology 1.7k
- Cancer Research 319
- Hematology 220
Countries citing papers authored by Stéphane Depil
This map shows the geographic impact of Stéphane Depil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Depil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Depil more than expected).
Fields of papers citing papers by Stéphane Depil
This network shows the impact of papers produced by Stéphane Depil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Depil. The network helps show where Stéphane Depil may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Depil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges Hit paper breakdown → | 2020 | 824 |
| 2 | Cold Tumors: A Therapeutic Challenge for Immunotherapy Hit paper breakdown → | 2019 | 797 |
| 3 | TCR-engineered T cell therapy in solid tumors: State of the art and perspectives Hit paper breakdown → | 2023 | 223 |
| 4 | 2013 | 177 | |
| 5 | 2017 | 143 | |
| 6 | 2019 | 123 | |
| 7 | 2013 | 119 | |
| 8 | 2013 | 113 | |
| 9 | 2002 | 103 | |
| 10 | Development of NK cell-based cancer immunotherapies through receptor engineering Hit paper breakdown → | 2024 | 100 |
| 11 | 2019 | 99 | |
| 12 | 2013 | 74 | |
| 13 | 2019 | 74 | |
| 14 | 2012 | 71 | |
| 15 | 2015 | 64 | |
| 16 | 2022 | 63 | |
| 17 | 2019 | 52 | |
| 18 | 2020 | 52 | |
| 19 | 2004 | 46 | |
| 20 | 2006 | 44 |
About Stéphane Depil
Stéphane Depil is a scholar working on Molecular Biology, Oncology, Immunology, Hematology and Pathology and Forensic Medicine, having authored 70 papers that have together received 4.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (12 papers), Histone Deacetylase Inhibitors Research (10 papers), Protein Degradation and Inhibitors (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (6 papers) and vaccines and immunoinformatics approaches (6 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.6k citations), Molecular Biology (1.7k citations), Cancer Research (319 citations) and Hematology (220 citations). Stéphane Depil has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Laurent Poirot, Philippe Duchâteau, G J Mufti, Stephan A. Grupp, Vincent Alcazer, Christophe Caux, Jenny Valladeau‐Guilemond, Paola Bonaventura, Tala Shekarian and Sandrine Valsesia‐Wittmann. Their work appears in journals such as Cancer Research, European Journal of Cancer, Annals of Oncology, Molecular Cancer Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.